These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

566 related articles for article (PubMed ID: 24507158)

  • 1. Interleukin 10 receptor signaling: master regulator of intestinal mucosal homeostasis in mice and humans.
    Shouval DS; Ouahed J; Biswas A; Goettel JA; Horwitz BH; Klein C; Muise AM; Snapper SB
    Adv Immunol; 2014; 122():177-210. PubMed ID: 24507158
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interleukin 1β Mediates Intestinal Inflammation in Mice and Patients With Interleukin 10 Receptor Deficiency.
    Shouval DS; Biswas A; Kang YH; Griffith AE; Konnikova L; Mascanfroni ID; Redhu NS; Frei SM; Field M; Doty AL; Goldsmith JD; Bhan AK; Loizides A; Weiss B; Yerushalmi B; Yanagi T; Lui X; Quintana FJ; Muise AM; Klein C; Horwitz BH; Glover SC; Bousvaros A; Snapper SB
    Gastroenterology; 2016 Dec; 151(6):1100-1104. PubMed ID: 27693323
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alterations in T and B Cell Receptor Repertoires Patterns in Patients With IL10 Signaling Defects and History of Infantile-Onset IBD.
    Werner L; Lee YN; Rechavi E; Lev A; Yerushalmi B; Ling G; Shah N; Uhlig HH; Weiss B; Somech R; Snapper SB; Shouval DS
    Front Immunol; 2020; 11():109. PubMed ID: 32117262
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced TH17 Responses in Patients with IL10 Receptor Deficiency and Infantile-onset IBD.
    Shouval DS; Konnikova L; Griffith AE; Wall SM; Biswas A; Werner L; Nunberg M; Kammermeier J; Goettel JA; Anand R; Chen H; Weiss B; Li J; Loizides A; Yerushalmi B; Yanagi T; Beier R; Conklin LS; Ebens CL; Santos FGMS; Sherlock M; Goldsmith JD; Kotlarz D; Glover SC; Shah N; Bousvaros A; Uhlig HH; Muise AM; Klein C; Snapper SB
    Inflamm Bowel Dis; 2017 Nov; 23(11):1950-1961. PubMed ID: 29023267
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development, validation and implementation of an in vitro model for the study of metabolic and immune function in normal and inflamed human colonic epithelium.
    Pedersen G
    Dan Med J; 2015 Jan; 62(1):B4973. PubMed ID: 25557335
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phenotypic Characterization of Very Early-Onset Inflammatory Bowel Disease with Interleukin-10 Signaling Deficiency: Based on a Large Cohort Study.
    Zheng C; Huang Y; Hu W; Shi J; Ye Z; Qian X; Huang Z; Xue A; Wang Y; Lu J; Tang Z; Wu J; Wang L; Peng K; Zhou Y; Miao S; Sun H
    Inflamm Bowel Dis; 2019 Mar; 25(4):756-766. PubMed ID: 30212871
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Defective IL10 signaling defining a subgroup of patients with inflammatory bowel disease.
    Begue B; Verdier J; Rieux-Laucat F; Goulet O; Morali A; Canioni D; Hugot JP; Daussy C; Verkarre V; Pigneur B; Fischer A; Klein C; Cerf-Bensussan N; Ruemmele FM
    Am J Gastroenterol; 2011 Aug; 106(8):1544-55. PubMed ID: 21519361
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The clinical, molecular, and therapeutic features of patients with IL10/IL10R deficiency: a systematic review.
    Sharifinejad N; Zaki-Dizaji M; Sepahvandi R; Fayyaz F; Dos Santos Vilela MM; ElGhazali G; Abolhassani H; Ochs HD; Azizi G
    Clin Exp Immunol; 2022 Jun; 208(3):281-291. PubMed ID: 35481870
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Innate Lymphoid Cells in Intestinal Homeostasis and Inflammatory Bowel Disease.
    Saez A; Gomez-Bris R; Herrero-Fernandez B; Mingorance C; Rius C; Gonzalez-Granado JM
    Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299236
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inflamed gut mucosa: downstream of interleukin-10.
    Paul G; Khare V; Gasche C
    Eur J Clin Invest; 2012 Jan; 42(1):95-109. PubMed ID: 21631466
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interleukin-10 and interleukin-10-receptor defects in inflammatory bowel disease.
    Shah N; Kammermeier J; Elawad M; Glocker EO
    Curr Allergy Asthma Rep; 2012 Oct; 12(5):373-9. PubMed ID: 22890722
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunopathology of inflammatory bowel disease.
    Wallace KL; Zheng LB; Kanazawa Y; Shih DQ
    World J Gastroenterol; 2014 Jan; 20(1):6-21. PubMed ID: 24415853
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Restored Macrophage Function Ameliorates Disease Pathophysiology in a Mouse Model for IL10 Receptor-deficient Very Early Onset Inflammatory Bowel Disease.
    Ackermann M; Mucci A; McCabe A; Frei S; Wright K; Snapper SB; Lachmann N; Williams DA; Brendel C
    J Crohns Colitis; 2021 Sep; 15(9):1588-1595. PubMed ID: 33596307
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potential roles of neutrophils in regulating intestinal mucosal inflammation of inflammatory bowel disease.
    Zhou GX; Liu ZJ
    J Dig Dis; 2017 Sep; 18(9):495-503. PubMed ID: 28857501
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current concepts in pediatric inflammatory bowel disease; IL10/IL10R colitis as a model disease.
    Almana Y; Mohammed R
    Int J Pediatr Adolesc Med; 2019 Mar; 6(1):1-5. PubMed ID: 31304220
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ILC3 function as a double-edged sword in inflammatory bowel diseases.
    Zeng B; Shi S; Ashworth G; Dong C; Liu J; Xing F
    Cell Death Dis; 2019 Apr; 10(4):315. PubMed ID: 30962426
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interleukin-10 receptor signaling in innate immune cells regulates mucosal immune tolerance and anti-inflammatory macrophage function.
    Shouval DS; Biswas A; Goettel JA; McCann K; Conaway E; Redhu NS; Mascanfroni ID; Al Adham Z; Lavoie S; Ibourk M; Nguyen DD; Samsom JN; Escher JC; Somech R; Weiss B; Beier R; Conklin LS; Ebens CL; Santos FG; Ferreira AR; Sherlock M; Bhan AK; Müller W; Mora JR; Quintana FJ; Klein C; Muise AM; Horwitz BH; Snapper SB
    Immunity; 2014 May; 40(5):706-19. PubMed ID: 24792912
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phenotypic characterization of very early-onset IBD due to mutations in the IL10, IL10 receptor alpha or beta gene: a survey of the Genius Working Group.
    Pigneur B; Escher J; Elawad M; Lima R; Buderus S; Kierkus J; Guariso G; Canioni D; Lambot K; Talbotec C; Shah N; Begue B; Rieux-Laucat F; Goulet O; Cerf-Bensussan N; Neven B; Ruemmele FM
    Inflamm Bowel Dis; 2013 Dec; 19(13):2820-8. PubMed ID: 24216686
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mast Cells Exert Anti-Inflammatory Effects in an IL10
    Lennon EM; Borst LB; Edwards LL; Moeser AJ
    Mediators Inflamm; 2018; 2018():7817360. PubMed ID: 29849494
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Innate immune signalling at intestinal mucosal surfaces: a fine line between host protection and destruction.
    Cario E
    Curr Opin Gastroenterol; 2008 Nov; 24(6):725-32. PubMed ID: 19122523
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.